Insider Buying: Cardlytics (NASDAQ:CDLX) CFO Purchases 50,000 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO David Thomas Evans purchased 50,000 shares of the business’s stock in a transaction on Monday, May 18th. The stock was purchased at an average cost of $0.63 per share, for a total transaction of $31,500.00. Following the acquisition, the chief financial officer owned 317,930 shares in the company, valued at approximately $200,295.90. The trade was a 18.66% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

David Thomas Evans also recently made the following trade(s):

• On Friday, May 15th, David Thomas Evans purchased 150,000 shares of Cardlytics stock. The stock was purchased at an average cost of $0.65 per share, for a total transaction of $97,500.00.

Cardlytics Price Performance

Cardlytics stock traded down $0.01 during trading hours on Tuesday, reaching $0.60. The stock had a trading volume of 869,236 shares, compared to its average volume of 1,103,752. The stock has a market cap of $34.34 million, a PE ratio of -0.34 and a beta of 0.67. Cardlytics, Inc. has a 52 week low of $0.57 and a 52 week high of $3.28. The company has a fifty day simple moving average of $0.87 and a 200-day simple moving average of $1.06.

Cardlytics (NASDAQ:CDLX) last released its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). The business had revenue of $56.10 million for the quarter, compared to the consensus estimate of $54.46 million. Cardlytics had a negative net margin of 46.03% and a negative return on equity of 956.56%. Research analysts predict that Cardlytics, Inc. will post -0.11 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Several hedge funds have recently made changes to their positions in CDLX. Vanguard Personalized Indexing Management LLC purchased a new position in Cardlytics during the 3rd quarter valued at about $26,000. Virtu Financial LLC purchased a new position in Cardlytics during the 4th quarter valued at about $39,000. Qube Research & Technologies Ltd purchased a new position in Cardlytics during the 3rd quarter valued at about $55,000. Marshall Wace LLP purchased a new position in Cardlytics during the 2nd quarter valued at about $59,000. Finally, Renaissance Technologies LLC purchased a new position in Cardlytics during the 4th quarter valued at about $62,000. 68.10% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have commented on CDLX shares. Evercore set a $1.00 price target on Cardlytics in a research report on Friday, March 6th. Wall Street Zen upgraded shares of Cardlytics from a “sell” rating to a “hold” rating in a report on Saturday, April 4th. Lake Street Capital set a $1.00 price target on shares of Cardlytics in a report on Friday, May 8th. Bank of America reiterated an “underperform” rating on shares of Cardlytics in a report on Thursday, March 5th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a report on Friday, April 10th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Cardlytics has a consensus rating of “Sell” and an average price target of $1.00.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.